Pediatric Transplantation

Article	Citations
The pediatric solid organ transplant experience with COVID‐19: An initial multi‐center, multi‐organ case series	54
Attitudes toward xenotransplantation: A survey of parents and pediatric cardiac providers	32
Psychological functioning and psychosocial issues in pediatric kidney transplant recipients	27
Donor‐derived cell‐free DNA (dd‐cfDNA) for detection of allograft rejection in pediatric kidney transplants	23
Stable liver graft post anti‐PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma	22
Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid‐resistant nephrotic syndrome	21
Post‐traumatic stress as a determinant of quality of life in pediatric solid‐organ transplant recipients	21
Low renal transplantation rates in children with end‐stage kidney disease: A study of barriers in a low‐resource setting	20
Religious and cultural aspects of organ donation: Narrowing the gap through understanding different religious beliefs	20
Treatment of post‐transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T‐cell therapy	18
Early findings after integration of donor‐derived cell‐free DNA into clinical care following pediatric heart transplantation	15
Factors associated with long‐term graft survival in pediatric kidney transplant recipients	15
Low psoas muscle index as an unfavorable factor in children with end‐stage liver disease undergoing liver transplantation	15
Impact of sarcopenia in infants with liver transplantation for biliary atresia	14
Restoration of nocturnal blood pressure dip and reduction of nocturnal blood pressure with evening anti‐hypertensive medication administration in pediatric kidney transplant recipients: A pilot random	14
Variability in clinical decision‐making for ventricular assist device implantation in pediatrics	14
To treat or not to treat: CFTR modulators after lung transplantation	14
A single‐center report of COVID‐19 disease course and management in liver transplanted pediatric patients	13
Use of a donor‐derived cell‐free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejection	13
De novo collapsing glomerulopathy in a pediatric kidney transplant recipient with COVID‐19 infection	13
Update on COVID‐19 vaccination in pediatric solid organ transplant recipients	13
State of pediatric liver transplantation in the United States and achieving zero wait list mortality with ideal outcomes: A statement from the Starzl Network for Excellence in Pediatric Transplant Sur	13
Induction and maintenance immunosuppression in pediatric kidney transplantation—Advances and controversies	12
COVID‐19 infection in pediatric solid organ transplant patients	12
Augmented immunosuppression and PTCY‐based haploidentical hematopoietic stem cell transplantation for thalassemia major	11

Outflow vein venoplasty of left lateral section graft for living donor liver transplantation in infant recipients	11
Treatment of BK virus with a stepwise immunosuppression reduction and intravenous immunoglobulin in pediatric kidney transplant	11
Changing racial and ethnic differences for lung transplantation in cystic fibrosis	11
The kidney allocation system and pediatric transplantation at 5 years	10
An appraisal of technical variant grafts compared to whole liver grafts in pediatric liver transplant recipients: Multicenter analysis from the SPLIT registry	10
Understanding disparities and barriers associated with pediatric transplant evaluation and time to listing: Moving toward a more comprehensive picture	10
C1q‐binding DSA and allograft outcomes in pediatric kidney transplant recipients	10
Multicenter data to improve health for pediatric renal transplant recipients in North America: Complementary approaches of NAPRTCS and IROC	10
Acute kidney disease predicts chronic kidney disease in pediatric non‐kidney solid organ transplant patients	10
Surgical complications in pediatric kidney transplantation—Incidence, risk factors, and effects on graft survival: A retrospective single‐center study	10
Living donor liver transplantation for hepatic malignancies in children	10
Psychosocial situation, adherence, and utilization of video consultation in young adult long‐term pediatric liver transplant recipients during COVID‐19 pandemic	10
CMV infection and management among pediatric solid organ transplant recipients	10
Post‐transplant malignancies in pediatric organ transplant recipients	10
Presentation and outcomes of post‐transplant lymphoproliferative disorder at a single institution pediatric transplant center	10
Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation in children: Single‐centre experience	10
Learning networks in pediatric heart failure and transplantation	10
The case against COVID‐19 vaccine mandates in pediatric solid organ transplantation	10
A systematic review of social determinants of health in pediatric organ transplant outcomes	10
Outcomes of allogeneic transplantation for hemoglobin Bart’s hydrops fetalis syndrome in Hong Kong	10
Fontan‐associated plastic bronchitis waitlist and heart transplant outcomes: A PHTS analysis	9
Prophylactic antithrombotic management in adult and pediatric kidney transplantation: A systematic review and meta‐analysis	9
Empowering patients to adhere to their treatment regimens: A multifaceted approach	9
Illness perceptions and beliefs about medication: impact on health‐related quality of life in adolescent kidney transplant recipients	9
Paediatric kidney transplantation: Towards a framework for pretransplant urological evaluation	9
Early school‐age cognitive performance post–pediatric heart transplantation	9
Focal segmental glomerulosclerosis: Risk for recurrence and interventions to optimize outcomes following recurrence	9
Exploring the potential for online peer support mentorship: Perspectives of pediatric solid organ transplant patients	9
Examining the association of medical complications and posttraumatic stress symptoms in pediatric solid organ transplant patients and their caregivers	9
Safety of LAVs administered after pediatric LT	9
Kidney transplantation in children with CAKUT and non‐CAKUT causes of chronic kidney disease: Do they have the same outcomes?	9
Impact of tacrolimus variability on pediatric heart transplant outcomes	9
Non‐operative management of biliary complications after Liver Transplantation in pediatric patients: A 30‐year experience	8
Early surveillance biopsy utilization and management of pediatric renal allograft acute T cell–mediated rejection in Canadian centers: Observations from the PROBE multicenter cohort study	8
Hematopoietic stem cell transplantation in serine/threonine kinase 4 (STK4) deficiency: Report of two cases and literature review	8
Cardiac allograft vasculopathy: A review	8
Comparison of cystatin C, creatinine, and iohexol clearance in pediatric liver transplantation—a retrospective cohort study	8
A case of treatment‐resistant membranous nephropathy associated with graft versus host disease successfully treated with daratumumab	8
Long‐term liver transplant outcomes for progressive familial intrahepatic cholestasis type 1: The Pittsburgh experience	8
COVID‐19 infection in a pediatric kidney transplant population: A single‐center experience	8
Percutaneous transhepatic interventional therapy of portal vein stenosis in paediatric liver transplantation: A systematic review of efficacy and safety	8
The mental health profiles of pediatric organ transplant recipients	8
Long‐term outcome after liver transplantation in children with type 1 glycogen storage disease	8
Liver transplant in a recently COVID‐19 positive child with hepatoblastoma	8
Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: A retrospective analysis of the UNOS/OPTN database	8
Family functioning in pediatric heart transplantation: Variables associated with poor outcomes	8
SARS‐CoV‐2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation—A case report	8
Large for size in pediatrics liver transplant using left lateral segment grafts: A single center experience	8
Examining racial and socioeconomic disparity in the pediatric heart transplant evaluation	8
Long‐term psychosocial outcomes of adults transplanted in childhood: A social work perspective	7

Psychosocial outcomes in pediatric patients with ventricular assist devices and their families: A systematic review	7
Heterogeneous outcomes of liver disease after heart transplantation for a failed Fontan procedure	7
Diagnostic performance of 2D‐shear wave elastography and serum fibrosis markers for evaluation of hepatic graft fibrosis in pediatric liver‐inclusive transplant recipients: A prospective pilot study	7
Robotic monosegment donor hepatectomy for pediatric liver transplantation: First report	7
Epstein–Barr virus‐associated risk factors for post‐transplant lymphoproliferative disease in pediatric liver transplant recipients	7
Adherence to laboratory testing in pediatric liver transplant recipients	7
Full left/full right liver graft ex situ split during hypothermic oxygenated perfusion	7
Age‐ and sex‐mediated differences in T lymphocyte populations of kidney transplant recipients	7
Care processes and structures associated with higher medication adherence in adolescent and young adult transplant recipients	7
The extracorporeal circulation with transdiaphragmatic approach in living‐donor liver transplantation for HB with atrial extension of tumor thrombus: A case report	7
Hepatic artery reconstruction using an operating microscope in pediatric liver transplantation—Is it worth the effort?	7
Time is of the essence: A single‐center experience of hepatic arterial supply impairment management in pediatric liver transplant recipients	7
Usability of intraoperative cine‐portogram during liver transplantation in young pediatric patients with biliary atresia	7
Reflecting on patient‐generated photographs of the pediatric renal transplant experience	7
Variation in immunosuppression practices among pediatric liver transplant centers—Society of Pediatric Liver Transplantation survey results	7
Preoperative echocardiographic parameters predict primary graft dysfunction following pediatric lung transplantation	7
The IPTA Nashville consensus conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: II—consensus guidelines for pre	7
Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successes	7
Outcomes of liver transplantation for mitochondrial respiratory chain disorder in children	7
Kidney transplantation in low weight pediatric recipients from adult donors: The short‐ And the long‐term outcomes	7
The potential of genetically engineered pig heart transplantation in infants with complex congenital heart disease	7
Practice variation in the immediate postoperative care of pediatric liver transplant patients: Framework for a national consensus	7
Isolated nocturnal hypertension in pediatric kidney transplant recipients	7
Management and outcome of hepatic artery thrombosis after pediatric liver transplantation	7
CD34+ selected peripheral blood Stem Cell Boost (SCB) for Poor Graft Function (PGF) or mixed chimerism in pediatric patients, after hematopoietic stem cell transplantation: Results of a retrospective	6
Extracorporeal membrane oxygenation and paracorporeal lung assist devices as a bridge to pediatric lung transplantation	6
Feasibility of using a patient‐reported outcome measure into clinical practice following pediatric liver transplantation: The Starzl Network experience	6
Yield and utility of surveillance kidney biopsies in pediatric kidney transplant recipients at various time points post‐transplant	6
Motor outcomes in young children pre‐and one‐year post‐liver transplant	6
Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease—A single center experience	6
Allogeneic hematopoietic stem cell transplant in pediatric acute myeloid leukemia: Lessons learnt from a tertiary care center in India	6
Understanding Substance use Policies and Associated Ethical Concerns: A survey of Pediatric Transplant Centers	6
Utility of pre‐transplant lower urinary tract investigation in pediatric renal transplant population after referral: A 16‐year institutional experience	6
Treatment adherence and behavior of pediatric liver transplant recipients during the COVID‐19 pandemic	6
Our evolution in the treatment of hepatic artery and portal vein thrombosis in pediatric liver transplantation: Success with catheter‐directed therapies	6
Impact of a clinical pathway on acute kidney injury in patients undergoing heart transplant	6
The outcome and complications of total parenteral nutrition in pediatric hematopoietic stem cell transplantation	6
When immunosuppression and COVID‐19 intersect: An exploratory qualitative study of young lung transplant recipient perceptions of daily life during a pandemic	6
Pediatric donor heart acceptance practices in the United States: What is really being considered?	6
Directly observed therapy to promote medication adherence in adolescent heart transplant recipients	6
Relationship between donor fraction cell‐free DNA and clinical rejection in heart transplantation	6
Primary pediatric live‐donor‐kidney transplant‐recipients' outcomes by immunosuppression induction received in the United States	6
Sarcopenia prevalence in pediatric intestinal transplant recipients: Implications on post‐transplant outcomes	6
Circumstances surrounding end‐of‐life in pediatric patients pre‐ and post‐heart transplant: a report from the Pediatric Heart Transplant Society	6
Use of Rituximab for persistent EBV DNAemia, and Its effect on donor‐specific antibody development in pediatric renal transplant recipients: A case series	6
Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation	6
Primary pediatric deceased‐donor kidney transplant recipients outcomes by immunosuppression induction received in the United States	6
Comparative analysis of outcomes and long‐term follow‐up of robot‐assisted pediatric kidney transplantation, with open counterpart	6
Interplay between donor and recipient factors impacts outcomes after pediatric heart transplantation: An analysis from the united network for organ sharing database	6
Neurocognitive deficits may not resolve following pediatric kidney transplantation	6
Mismatch epitope load predicts de novo‐DSA‐free survival in pediatric liver transplantation	6
Optimal graft size in pediatric living donor liver transplantation: How are children different from adults?	6
Diarrhea in the pediatric solid organ transplantation recipient: A multidisciplinary approach to diagnosis and management	6
Ehrlichia‐induced hemophagocytic lymphohistiocytosis in a pediatric kidney transplant recipient	6
Use of eltrombopag for the treatment of poor graft function after hematopoietic stem cell transplantation in children	6
Is primary hepatic angiosarcoma in children an indication for liver transplantation?—A single‐centre experience and review of the literature	6
Paraneoplastic pemphigus associated with post‐transplant lymphoproliferative disorder after small bowel transplantation	6
Do funding sources influence long‐term patient survival in pediatric liver transplantation?	6
Rejection surveillance in pediatric heart transplant recipients: Critical reflection on the role of frequent and long‐term routine surveillance endomyocardial biopsies and comprehensive review of non‐	6
Comparison of pediatric brain‐dead donors to donation after circulatory death donors in the United States	6
The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other	6
Predictors of portal vein complications after pediatric liver transplantation: A German center experience	6
Successful kidney transplantation in a patient with neonatal‐onset ILNEB	6
Reducing the wait: TCV can expand the donor pool for heart transplant candidates	6
Declining mortality rates in children admitted to ICU following HCT	6
Timing of native nephrectomy and kidney transplant outcomes in children	5
Comparison of levetiracetam versus phenytoin/fosphenytoin for busulfan seizure prophylaxis at a pediatric institution	5
Iron overload after allogeneic stem cell transplantation in children with acute lymphoblastic leukemia	5
Prediction, management, and prognosis of mixed chimerism after hematopoietic stem cell transplantation in transfusion‐dependent pediatric thalassemia patients	5
Decreased access to pediatric liver transplantation during the COVID‐19 pandemic	5
Impact of length of donor ICU stay on outcome of patients after pediatric liver transplantation with whole and in situ split liver grafts	5
Non‐HLA AT1R antibodies are highly prevalent after pediatric intestinal transplantation	5
Immediate extubation following pediatric liver transplantation	5
The effects of child anxiety and depression on concordance between parent‐proxy and self‐reported health‐related quality of life for pediatric liver transplant patients	5
Repeated CD45RA‐depleted DLI successfully increases donor chimerism in a patient with beta‐thalassemia major after haploidentical stem cell transplant	5
Equity factors in pediatric transplant listing: Initial findings from a single center review	5
Risk factors for post‐transplant Epstein‐Barr virus events in pediatric recipients of hematopoietic stem cell transplants	5
Impact of once‐daily ER‐Tac on trough concentration variability in a stable AYA renal transplant recipient cohort	5
Effect of magnification in pediatric liver transplantation: A systematic review and meta‐analysis	5
T cell phenotype in paediatric heart transplant recipients	5

Compare the performance of multiple machine learning models in predicting tacrolimus concentration for infant patients with living donor liver transplantation	5
Low CD4 count may be a risk factor for non‐tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients	5
Spotting a potential threat: Measles among pediatric solid organ transplantation recipients	5
Simultaneous pediatric heart‐kidney transplant outcomes in the US: A‐25 year National Cohort Study	5
Ventricular assist device support for children with chemotherapy‐induced cardiomyopathy and advanced heart failure: Perspectives gained from a single‐center experience	5
Early hepatic arterial thrombosis in liver transplantation: Systemic intravenous alteplase as a potential rescue treatment after failed surgical revascularization	5
Right heart failure considerations in pediatric ventricular assist devices	5
SARS‐CoV‐2 and pediatric solid organ transplantation: Current knowns and unknowns	5
The current state of pediatric transplant hepatology fellowships: A survey of recent graduates	5
Maternal versus paternal living kidney transplant donation is associated with lower rejection in young pediatric recipients: A Collaborative Transplant Study report	5
Successful global anti‐B‐cell strategy with daratumumab in a patient with post‐transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab	5
Pediatric lung transplant: Correlation of pretransplant condition with post‐transplant outcomes	5
Paediatric deceased donor kidney transplant in Australia: A 30‐year review—What have paediatric bonuses achieved and where to from here?	5
A text messaging intervention and quality of life in adolescents with solid organ transplants	5
Ultrasonographically guided percutaneous transhepatic liver biopsy after pediatric liver transplantation	5
An ethical analysis of obesity as a determinant of pediatric heart transplant candidacy	5
COVID‐19 vaccination in pediatric solid organ transplant recipients—Current state and future directions	5
Prospective Evaluation of the Fungitell® (1→3) Beta‐D‐Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from	5
The utility of native ureter in the management of ureteral complications in children after renal transplantation	5
Tacrolimus‐induced acute pancreatitis and diabetic ketoacidosis (DKA) in pediatric kidney transplant recipient	5
Obesity and dyslipidemia predict cardiac allograft vasculopathy and graft loss in children and adolescents post‐heart transplant: A PHTS multi‐institutional analysis	5
Allocation to pediatric recipients around the world: An IPTA global survey of current pediatric solid organ transplantation deceased donation allocation practices	5
Long‐term mortality in pediatric solid organ recipients—A nationwide study	5
Post‐operative fluid overload as a predictor of hospital and long‐term outcomes in a pediatric heart transplant population	5
Characteristics, risk factors, and outcomes of neutropenia after liver or kidney transplantation in children	5
Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: Efficacy and risk factors associated with failure of weight‐based dosed valganciclovir prop	5
Clinical Efficacy of Ruxolitinib Monotherapy and Haploidentical Hematopoeitic Stem Cell Transplantation in a Child with Philadelphia Chromosome‐like Relapsed/Refractory acute lymphoblastic leukemia	5
Abstract Supplement	5
Protein‐losing enteropathy recurrence after pediatric heart transplantation: Multicenter case series	4
Delayed sequential abdominal wall closure in pediatric liver transplantation to overcome “large for size” scenarios	4
Promoting bone health in children and adolescents following solid organ transplantation	4
Dexmedetomidine leading to profound bradycardia in a pediatric liver transplant recipient	4
A Neonatal ABO non‐compatible heart transplant from a circulatory‐determined death donor using NRP/Cold storage	4
Percutaneous endovascular management of ascending aortic pseudoaneurysm after heart transplantation in a pediatric patient	4
Use of belatacept as alternative graft vs host disease prophylaxis in pediatric allogeneic hematopoietic stem cell transplantation	4
Exploring the ethical complexity of pediatric organ transplant candidates and COVID‐19 vaccination: Tensions between autonomy and beneficence, children and parents	4
Kidney transplant outcomes in children and adolescents with systemic lupus erythematosus	4
Kaposi sarcoma in three pediatric liver transplantation recipients	4
Self‐reported quality of life in children with ventricular assist devices	4
Promoting safe sexual practices and sexual health maintenance in pediatric and young adult solid organ transplant recipients	4
Sequential paternal haploidentical donor liver and HSCT in EPP allow discontinuation of immunosuppression post‐organ transplant	4
Low post‐transplant measles and varicella titers among pediatric liver transplant recipients: A 10‐year single‐center study	4
Addition of ruxolitinib in Graft‐versus‐Host disease prophylaxis for pediatric β‐Thalassemia major patients after allogeneic stem cell transplantation: A retrospective cohort stu	4
Vaccine‐induced protection against hepatitis B in pediatric solid organ transplant patients	4
Co‐transplantation of bone marrow‐derived mesenchymal stem cells with hematopoietic stem cells does not improve transplantation outcome in class III beta‐thalassemia major: A prospective cohort study	4
Gastrointestinal symptoms and endoscopy findings after pediatric solid organ transplantation: A case series	4
Three decades of collaboration through the Pediatric Heart Transplant Society Registry: A journey through registry data with a highlight on children with single ventricle anatomy	4
Solid organ transplant–specific antibiogram in a tertiary pediatric hospital in Canada	4
Quality of life in long term survivors of pediatric intestinal transplantation compared with liver transplantation and home parenteral nutrition: A prospective single‐center pilot study	4
Human papillomavirus‐related cancer risk for solid organ transplant recipients during adult life and early prevention strategies during childhood and adolescence	4
Cardiac magnetic resonance diastolic indices correlate with ventricular filling pressures in pediatric heart transplant recipients	4
Eligible neonatal donors after circulatory determination of death (Maastricht type III): A national survey of level III NICUs	4
Lack of persisting antibody in a post‐transplant patient after vaccine‐strain varicella	4
Surgical technique and the long‐term outcomes of pediatric living donor domino liver transplantation from patients with maple syrup urine disease	4
HSCT with mismatched unrelated donors: Bone marrow versus peripheral blood stem cells sources in pediatric patients	4
Pediatric KT in children up to 15 kg: A single‐center experience	4
Long‐term outcome of early steroid withdrawal in pediatric renal transplantation	4
Vaccination practices in pediatric transplantation: A survey among member centers of the European reference network TransplantChild	4
Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC)	4
Fontan‐associated liver disease after heart transplant	4
Pediatric liver transplantation activity in a high‐volume program during the COVID‐19 pandemic in Brazil	4
Successful ABO incompatible heart transplantation after desensitization therapy in an older child	4
αβ+/CD19+‐depleted haploidentical stem cell transplantation for children with acute leukemia: Is there a protective effect of increased γδ+ T‐cell content i	4
Adherence in pediatric renal recipients and its effect on graft outcome, a single‐center, retrospective study	4
Stem cell transplantation for pediatric patients with adrenoleukodystrophy: A nationwide retrospective analysis in Japan	4
Allogeneic hematopoietic stem cell transplantation in patients with childhood cerebral adrenoleukodystrophy: A single‐center experience “Better prognosis in earlier stage”	4
Is the atypical hemolytic uremic syndrome risk polymorphism in Membrane Cofactor Protein MCPggaac relevant in kidney transplantation? A case report	4
Pediatric impacts of multiorgan transplant allocation policy in the United States	4
Course of renal allograft function after diagnosis and treatment of post‐transplant lymphoproliferative disorders in pediatric kidney transplant recipients	4
Outcomes after liver transplantation in MPV17 deficiency (Navajo neurohepatopathy): A single‐center case series	4
Enabling successful transition—Evaluation of a transition to adult care program for pediatric liver transplant recipients	4
Vitamin D has no impact on outcomes after HSCT in children—A retrospective study	4
Low‐dose steroids do make a difference: Independent risk factors for impaired linear growth after pediatric liver transplantation	4
Operational tolerance after pediatric composite liver‐pancreas‐intestine transplantation following severe graft‐versus‐host disease	4
Steroid avoidance/withdrawal and maintenance immunosuppression in pediatric kidney transplantation	4
Reappraisal of liver transplantation for erythropoietic protoporphyria: A deadly combination of disease recurrence and biliary complication	4
Preparing for the 2020—2021 influenza season	4
Late first acute rejection in pediatric kidney transplantation: A North American Pediatric Renal Trials and Collaborative Studies special study	4
Good outcomes after pediatric intraperitoneal kidney transplant	4
Fatal Epstein‐Barr virus‐associated hemophagocytic lymphohistiocytosis with virus‐infected T cells after pediatric multivisceral transplantation: A proof‐of‐concept case report	4
High‐flow nasal cannula oxygen therapy: Alternative respiratory therapy for severe post‐transplant hypoxemia in children with hepatopulmonary syndrome	4
Predictors of patient and graft survival following pediatric liver transplantation: Long‐term analysis of more than 300 cases from single centre	4
Impact of institutional routine surveillance endomyocardial biopsy frequency in the first year on rejection and graft survival in pediatric heart transplantation	4
The IPTA Nashville consensus conference on post‐transplant lymphoproliferative disorders after solid organ transplantation in children: I—Methodology for the development of consensus practi	4
Effect of ischemic time on pediatric heart transplantation outcomes: is it the same for all allografts?	4
Burnout, professional fulfillment, and post‐traumatic stress among pediatric solid organ transplant teams	4
Course of vitamin D levels before and after liver transplantation in pediatric patients	4
Allogeneic hematopoietic stem cell transplantation in infants is associated with significant morbidity and mortality	4
Long‐term experience using CNI‐free immunosuppression in selected paediatric heart transplant recipients	4
Thromboprophylaxis after kidney transplantation in children: Ten‐year experience of a single Brazilian center	4
Double‐unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA‐identical sibling bone marrow transplantation	3
Diagnosis and treatment of cryptococcal osteomyelitis in a pediatric lung transplant patient	3
Irradiation‐free RIC HSCT has a tolerable safety profile and is effective therapy for pediatric bone marrow failure syndromes	3
Changes in circumferential strain can differentiate pediatric heart transplant recipients with and without graft rejection	3
Safety and feasibility of immediate tracheal extubation of small pediatric patients after living donor liver transplantation	3